Detalles de la búsqueda
1.
Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia.
Cancer
; 128(15): 2922-2931, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35612815
2.
Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial.
Am J Hematol
; 97(8): 1023-1034, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35617104
3.
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.
Ann Hematol
; 100(4): 959-968, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33191481
4.
CD52-negative T cells predict acute graft-versus-host disease after an alemtuzumab-based conditioning regimen.
Br J Haematol
; 191(2): 253-262, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32410220
5.
Diagnosis of sinusoidal obstruction syndrome: can biopsy be the key?
Ann Hematol
; 102(12): 3635-3637, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37740063
6.
Dermatopathic lymphadenopathy with Langerhans cell chimerism in graft-versus-host disease of the skin.
Eur J Haematol
; 99(6): 582-585, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28888027
7.
Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.
Ann Hematol
; 100(8): 2141-2142, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34160650
8.
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison.
Bone Marrow Transplant
; 59(5): 670-679, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38383713
9.
Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA study.
Bone Marrow Transplant
; 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38698080
10.
Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party.
Bone Marrow Transplant
; 59(2): 247-254, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38040842
11.
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation.
Bone Marrow Transplant
; 59(2): 217-223, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37978322
12.
Donor KIR genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight.
Front Immunol
; 15: 1350470, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38629074
13.
Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial.
Lancet Haematol
; 11(5): e324-e335, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38583455
14.
Veno-occlusive disease of the lung after allogeneic haematopoietic stem-cell transplantation: An autopsy study.
Pathol Res Pract
; 231: 153799, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35180649
15.
Thiotepa-fludarabine-treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trial.
Bone Marrow Transplant
; 57(11): 1664-1670, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35982219
16.
Alloimmune Myositis as Paraneoplastic Complication of an Oral Squamous Cell Carcinoma After Severe Chronic Graft vs Host Disease or a Manifestation of Chronic Graft vs Host Disease? A Case Report and Literature Discussion.
Transplant Proc
; 53(4): 1365-1368, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33478746
17.
An investigation of the diagnostic, predictive, and prognostic impacts of three colonic biopsy grading systems for acute graft versus host disease.
PLoS One
; 16(8): e0256543, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34437603
18.
Predictive Factors for Outcome of First Allogeneic Transplant for Elderly Patients With Acute Lymphoblastic Leukemia.
Clin Lymphoma Myeloma Leuk
; 21(12): 831-840, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34373225
19.
Allogeneic HCT for adults with B-cell precursor acute lymphoblastic leukemia harboring IKZF1 gene mutations. A study by the Acute Leukemia Working Party of the EBMT.
Bone Marrow Transplant
; 56(5): 1047-1055, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33235351
20.
Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial.
Bone Marrow Transplant
; 56(3): 635-645, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33028987